C. Sherr

发表

p53-independent functions of the p19(ARF) tumor suppressor.

M. Roussel, J. Rehg, G. Lozano, 2000, Genes & development.

The ARF/p53 pathway.

J. D. Weber, C. Sherr, J. Weber, 2000, Current opinion in genetics & development.

Principles of Tumor Suppression

C. Sherr, Charles J Sherr, 2004, Cell.

A signaling to p 53 involves the p 19 ARF tumor suppressor

S. Lowe, F. Zindy, M. Roussel, 1998 .

Tumor surveillance via the ARF-p53 pathway.

C. Sherr, C J Sherr, 1998, Genes & development.

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF

Richard A. Ashmun, James R. Downing, Charles J. Sherr, 1997, Cell.

Cancer Cell Cycles

C. Sherr, 1996, Science.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

J L Cleveland, F. Zindy, M. Roussel, 1998, Genes & development.

CDK inhibitors: positive and negative regulators of G1-phase progression.

James M. Roberts, C. Sherr, J. Roberts, 1999, Genes & development.

The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts

James M. Roberts, Paul Olivier, M. Roussel, 1999, The EMBO journal.

The RB and p53 pathways in cancer.

F. McCormick, C. Sherr, 2002, Cancer cell.

The INK4a/ARF network in tumour suppression

Charles J. Sherr, C. Sherr, 2001, Nature Reviews Molecular Cell Biology.

Tumor Spectrum in ARF-deficient Mice 1

D. H. Randle, C. Sherr, T. Kamijo, 2000 .

deficient Mice ARF Tumor Spectrum in Updated Version

D. H. Randle, C. Sherr, T. Kamijo, 2000 .

p27KIP1 deletions in childhood acute lymphoblastic leukemia.

S. Raimondi, A. Look, M. Valentine, 1999, Neoplasia.

Tumor spectrum in ARF-deficient mice.

D. H. Randle, C. Sherr, T. Kamijo, 1999, Cancer research.

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.

F. Zindy, I. Stamenkovic, J. Jorcano, 1997, Genes & development.

Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases

M. Roussel, C. Sherr, M. Adachi, 1997 .

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

D. Quelle, C. Sherr, R. Ashmun, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

David M. Livingston, Charles J. Sherr, M. Ewen, 1993, Cell.

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

M. Ewen, C. Sherr, J. Kato, 1993, Genes & development.

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

James M. Roberts, J. Massagué, K. Polyak, 1994, Genes & development.

G1 phase progression: Cycling on cue

C. Sherr, 1994, Cell.

Rescue of defective mitogenic signaling by D-type cyclins.

M. Roussel, M. Pagano, C. Sherr, 1995, Proceedings of the National Academy of Sciences of the United States of America.

D-type cyclin-dependent kinase activity in mammalian cells

S. Shurtleff, M. Shibuya, D. Quelle, 1994, Molecular and cellular biology.

Tumor suppression by Ink4a-Arf: progress and puzzles.

S. Lowe, C. Sherr, Scott W Lowe, 2003, Current opinion in genetics & development.

Living with or without cyclins and cyclin-dependent kinases.

James M. Roberts, C. Sherr, 2004, Genes & development.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

F. Zindy, M. Roussel, G. Zambetti, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Mammalian G1 cyclins

Charles J. Sherr, C. Sherr, 1993, Cell.

Inhibitors of mammalian G1 cyclin-dependent kinases.

James M. Roberts, C. Sherr, J. Roberts, 1995, Genes & development.

Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation

J. Downing, C. Sherr, M. Ohtsuka, 1990 .

Baboons and their close relatives are unusual among primates in their ability to release nondefective endogenous type C viruses.

C. Sherr, G. Todaro, R. Benveniste, 1976, Virology.

Cellular senescence: mitotic clock or culture shock?

R. DePinho, C. Sherr, C J Sherr, 2000, Cell.

Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages

F. Zindy, M. Roussel, D. H. Randle, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.

F. Zindy, M. Roussel, D. H. Randle, 2001, Proceedings of the National Academy of Sciences of the United States of America.

N-terminal polyubiquitination and degradation of the Arf tumor suppressor.

Mei-Ling Kuo, Martine F Roussel, M. Roussel, 2004, Genes & development.

Sumoylation induced by the Arf tumor suppressor: a p53-independent function.

C. Sherr, S. Chiocca, K. Tago, 2005, Proceedings of the National Academy of Sciences of the United States of America.

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1

Charles J. Sherr, Martine F Roussel, A. Look, 1985, Cell.

macrophages stimulated by colony-stimulating factor 1 Cloning and expression of murine interleukin-1 receptor antagonist in

M. Roussel, K. Matsushima, C. Sherr, 2011 .

Oncogenic Potential of the c-FMS Proto-Oncogene (CSF-1 Receptor)

M. Roussel, C. Sherr, 2003, Cell cycle.

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

Richard A. Ashmun, Charles J. Sherr, Martine F. Roussel, 1991, Cell.

Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1.

M. Roussel, K. Matsushima, C. Sherr, 1991, Blood.

Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor

E. Reinherz, C. Sherr, J. Kato, 1990 .

Signal-response coupling mediated by the transduced colony-stimulating factor-1 receptor and its oncogenic fms variants in naive cells.

J. Downing, M. Roussel, C. Sherr, 1990, Ciba Foundation symposium.

Human colony-stimulating factor 1 (CSF-1) receptor confers CSF-1 responsiveness to interleukin-3-dependent 32DC13 mouse myeloid cells and abrogates differentiation in response to granulocyte CSF.

C. Sherr, J. Kato, 1990 .

Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes

C. Sherr, R. Ashmun, G. Borzillo, 1990, Molecular and Cellular Biology.

Functional expression of the human receptor for colony-stimulating factor 1 (CSF-1) in hamster fibroblasts: CSF-1 stimulates Na+/H+ exchange and DNA-synthesis in the absence of phosphoinositide breakdown.

M. Roussel, J. Pouysségur, K. Seuwen, 1990, Growth factors.

Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms

J. Downing, C. Sherr, M. Roussel, 1989 .

Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures

C. Sherr, G. Borzillo, 1989 .

The Macrophage Colony Stimulating Factor, CSF-1, and Its Receptor (c- fms )

C. Sherr, 1989 .

Inhibition of colony-stimulating factor-1 activity by monoclonal antibodies to the human CSF-1 receptor.

J. Downing, M. Roussel, C. Sherr, 1989, Blood.

Inhibition of colony-stimulating factor-1 activity by monoclonal antibodies to the human CSF-1 receptor.

J. Downing, M. Roussel, C. Sherr, 1989, Blood.

Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.

M. Roussel, C. Sherr, R. Ashmun, 1989, Blood.

Transduction of human colony-stimulating factor-1 (CSF-1) receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth

M. Roussel, C. Sherr, R. Ashmun, 1989, Molecular and Cellular Biology.

Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line

J. Downing, C. Sherr, C. W. Rettenmier, 1988 .

The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand

M. Roussel, C. Sherr, C. W. Rettenmier, 1988, Journal of Cell Science.

Colony‐stimulating factor‐1 receptor (c‐fms)

M. Roussel, C. Sherr, C. W. Rettenmier, 1988, Journal of cellular biochemistry.

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential

J. Downing, M. Roussel, C. Sherr, 1988, Cell.

Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF‐1 receptor)

C. Sherr, 1987, Journal of cellular physiology. Supplement.

Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes

M. Roussel, C. Sherr, R. Ashmun, 1987, Molecular and Cellular Biology.

Transforming potential of the c-fms proto-oncogene (CSF-1 receptor)

M. Roussel, A. Ullrich, T. Dull, 1987, Nature.

Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene

M. Roussel, C. Sherr, J. Heard, 1987, Cell.

Relationship of the c-fms Protooncogene Product to the CSF-1 Receptor

C. Sherr, 1987 .

The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1

J. Ihle, C. Sherr, D. Askew, 1987 .

Transforming Activity of the fms Oncogene (CSF-1 Receptor)

M. Roussel, C. Sherr, C. W. Rettenmier, 1987 .

Transformation by the v‐fms oncogene product: An analog of the CSF‐1 receptor

M. Roussel, C. Rock, C. Sherr, 1987, Journal of cellular biochemistry.

The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line

A. Look, C. Sherr, C. W. Rettenmier, 1986, Nature.

Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product.

J. H. Chen, C. Sherr, W. Furman, 1986, Virology.

Molecular cloning, expression, and chromosomal localization of the gene encoding a human myeloid membrane antigen (gp150).

M. Roussel, M. L. Le Beau, C. Sherr, 1986, The Journal of clinical investigation.

Amplification of genes encoding human myeloid membrane antigens after DNA-mediated gene transfer.

C. Sherr, S. Peiper, A. Look, 1986, Blood.

Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines.

M. Roussel, A. Nienhuis, C. Sherr, 1986, The Journal of clinical investigation.

Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q− syndrome

S. O’Brien, W. Nash, A. Nienhuis, 1985, Cell.

Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene

C. Sherr, L. Turek, S. Ruscetti, 1980, Journal of Virology.

Three independent isolates of feline sarcoma virus code for three distinct gag-x polyproteins

C. Sherr, L. Turek, S. Ruscetti, 1980, Journal of virology.

Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms

S. Anderson, C. Sherr, S. Ruscetti, 1982, Journal of virology.

McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms)

S. Anderson, C. Sherr, C. Garon, 1982, Journal of virology.

Molecular cloning of the c-fms locus and its assignment to human chromosome 5

F. Ruddle, C. Sherr, P. Barker, 1983, Journal of virology.

Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

F. Galibert, C. Sherr, A. Hampe, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity.

J. H. Chen, M. Roussel, C. Sherr, 1985, Science.

Transmembrane orientation of glycoproteins encoded by the v-fms oncogene

A. Look, M. Roussel, C. Sherr, 1985, Cell.

Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.

F. Zindy, C. Sherr, T. Kamijo, 1999, Cancer research.

Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

M. Roussel, J. Cleveland, J. Rehg, 2000, Genes & development.

Antagonism of Myc functions by Arf.

J. Cleveland, C. Sherr, 2004, Cancer cell.

Mouse medulloblastoma driven by CRISPR activation of cellular Myc

M. Roussel, Beisi Xu, D. Finkelstein, 2018, Scientific Reports.

Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3

C. Sherr, Mary C. Thomas, W. den Besten, 2008, Cell cycle.

Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor

M. Roussel, E. Reinherz, C. Sherr, 1990, Molecular and cellular biology.

Amplification of cyclin genes in colorectal carcinomas.

S. Elledge, K. Kinzler, B. Vogelstein, 1993, Cancer research.

Inhibition of cell proliferation by the Mad1 transcriptional repressor

M. Roussel, R. Eisenman, C. Sherr, 1996, Molecular and cellular biology.

Biologic and immunologic properties of porcine type C viruses.

C. Sherr, G. Todaro, M. Lieber, 1975, Virology.

Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression.

C. Sherr, J. W. Brewer, L. Hendershot, 1999, Proceedings of the National Academy of Sciences of the United States of America.

MAC-1, a new genetically transmitted type C virus of primates: “low frequency” activation from stumptail monkey cell cultures

C. Sherr, G. Todaro, R. Benveniste, 1978, Cell.

Tbx3, the ulnar‐mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53‐independent pathway

F. Zindy, C. Sherr, L. Jerome-Majewska, 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

D-type cyclin-dependent kinase activity in mammalian cells

S. Shurtleff, M. Shibuya, D. Quelle, 1994, Molecular and Cellular Biology.

Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase

D. Morgan, C. Sherr, R. P. Fisher, 1994 .

A MODEL FOR FOCMA EXPRESSION IN CELLS TRANSFORMED BY FELINE LEUKEMIA AND SARCOMA VIRUSES

C. Sherr, S. Ruscetti, L. Donner, 1980 .

Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein.

F. Zindy, M. Roussel, C. Sherr, 2004, Hybridoma and hybridomics.

Phospholipase C‐gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF‐1.

J. Downing, A. Ullrich, A. Zilberstein, 1989, The EMBO journal.

The ins and outs of RB: coupling gene expression to the cell cycle clock.

C. Sherr, 1994, Trends in cell biology.

Editorial overview checks and balances

C. Sherr, T. Hunt, 1994 .

The mononuclear phagocyte colony-stimulating factor (CSF-1, M-CSF).

C. Sherr, C. W. Rettenmier, 1989, Hematology/oncology clinics of North America.

Roberts progression-phase 1 CDK inhibitors : positive and negative regulators of G

C. Sherr, M. James, 1999 .

The CDK Inhibitor p18Ink4c is a Tumor Suppressor in Medulloblastoma

F. Zindy, M. Roussel, C. Sherr, 2006, Cell cycle.

An ArfGFP/GFP Indicator Mouse Reveals that the Arf Tumor Suppressor Monitors Latent Oncogenic Signals In Vivo

C. Sherr, 2004 .

Advances in Brief Amplification of Cyclin Genes in Colorectal Carcinomas 1

Stephen, B. Vogelstein, J. Willson, 2006 .

Amplification of Cyclin Genes in Colorectal Carcinomas1

B. Vogelstein, J. Willson, C. Sherr, 2006 .

Monoclonal antibodies to mammalian D-type G1 cyclins.

S. Shurtleff, M. Roussel, C. Sherr, 1994, Hybridoma.

Regulation of CYL/cyclin D genes by colony-stimulating factor 1.

M. Roussel, C. Sherr, H. Matsushime, 1992, Ciba Foundation symposium.

Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.

M. Roussel, C. Sherr, J. Weber, 2000, The Journal of biological chemistry.

Parsing Ink4a/Arf “Pure” p16-Null Mice

C. Sherr, 2001, Cell.

E1A signaling to p53 involves the p19 tumor suppressor

S. Lowe, F. Zindy, M. Roussel, 1998 .

Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism

C. Sherr, Kazushi Inoue, K. Inoue, 1998, Molecular and Cellular Biology.

Glycogen synthase kinase-3 b regulates cyclin D1 proteolysis and subcellular localization

M. Roussel, C. Sherr, M. Cheng, 1998 .

Two distinct endogenous type C viruses isolated from the asian rodent Mus cervicolor: conservation of virogene sequences in related rodent species

C. Sherr, R. Callahan, G. Todaro, 1977, Journal of virology.

Type C viruses from Kirsten sarcoma-transformed mink cells co-cultivated with primate cells and expressing p30 antigens related to feline leukemia virus

C. Sherr, G. Todaro, M. Lieber, 1976, Journal of virology.

Pastimes in Cancer Biology

C. Sherr, 2018 .

Restriction endonuclease mapping of unintegrated proviral DNA of Snyder-Theilen feline sarcoma virus: localization of sarcoma-specific sequences

C. Sherr, L. Turek, L. Donner, 1979, Journal of virology.

Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus

J. Maizel, G. Woude, C. Sherr, 1980, Journal of virology.

Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

A. Look, M. Valentine, C. Sherr, 1993, Cancer research.

Radioimmunoassay for Human Procollagen

C. Sherr, M. Taubman, B. Goldberg, 1974, Science.

Evolution of Primate Type-C Viral Genes

C. Sherr, R. Callahan, G. Todaro, 1975 .

Isolation and characterization of a new type D retrovirus from the asian primate, Presbytis obscurus (spectacled langur).

J. Stephenson, J. Schlom, C. Sherr, 1978, Virology.

The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

C. Sherr, R. Williams, 2007, Advances in experimental medicine and biology.

Control of Spermatogenesis in Mice by the Cyclin D-Dependent Kinase Inhibitors p18Ink4c and p19Ink4d

F. Zindy, M. Roussel, M. Barbacid, 2001, Molecular and Cellular Biology.

Cell cycle control and cancer.

C. Sherr, 2000, Harvey lectures.

Two Tumor Suppressors, p27Kip1 and Patched-1, Collaborate to Prevent Medulloblastoma

F. Zindy, M. Roussel, J. Rehg, 2009, Molecular Cancer Research.

Nucleotide sequences of feline sarcoma virus long terminal repeats and 5' leaders show extensive homology to those of other mammalian retroviruses

F. Galibert, C. Sherr, A. Hampe, 1983, Journal of virology.

Mutant Feline Sarcoma Proviruses Containing the Viral Oncogene (v-fes) and Either Feline or Murine Control Elements

F. Galibert, D. Lowy, J. Even, 1983, Journal of virology.

D1 in G2

C. Sherr, 2002 .

Control of G1 Progression by Mammalian D-Type Cyclins

M. Roussel, D. Quelle, C. Sherr, 1994 .

A new genetic locus, bevi, on human chromosome 6 which controls the replication of baboon type C virus in human cells

S. O’Brien, C. Sherr, R. Lemons, 1977, Cell.

A gene (Bevi) on human chromosome 6 is an integration site for baboon type C DNA provirus in human cells

S. O’Brien, W. Nash, C. Sherr, 1978, Cell.

Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150).

M. Roussel, C. Sherr, R. Ashmun, 1985, The Journal of clinical investigation.

Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line

J. Downing, C. Sherr, C. W. Rettenmier, 1988, Molecular and cellular biology.

Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.

C. Sherr, M. Essex, G. Todaro, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Preparation of rat monoclonal antibodies to epitopes encoded by the viral oncogene (v‐fms) of McDonough feline sarcoma virus

S. Anderson, C. Sherr, S. Ruscetti, 1982, Journal of cellular biochemistry.

Transformation-defective mutants of Snyder-Theilen feline sarcoma virus lack tyrosine-specific protein kinase activity

M. Barbacid, C. Sherr, S. Ruscetti, 1981, Journal of virology.

Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine model

M. Relling, Cheng Cheng, W. Evans, 2014, Pharmacogenetics and genomics.

Cloning and characterization of murine p16(INK4a) and p15(INK4b) genes

G. Hannon, M. Serrano, D. Beach, 1995 .

Transduction of human colony-stimulating factor-1 (CSF-1) receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth

M. Roussel, C. Sherr, R. Ashmun, 1989, Molecular and cellular biology.

The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences

A. Look, V. Fried, C. Sherr, 1986, Journal of virology.

p53-independent functions of the p19 tumor suppressor

M. Roussel, J. Rehg, G. Lozano, 2000 .

D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response.

M. Roussel, D. Quelle, C. Sherr, 1994, Cold Spring Harbor symposia on quantitative biology.

Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.

C. Sherr, E. Stanley, C. W. Rettenmier, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Specific binding of the type C viral core protein p12 with purified viral RNA

C. Sherr, G. Todaro, Arup Sen, 1976, Cell.

Molecular diversity among five different endogenous primate retroviruses

C. Sherr, G. Todaro, M. Bryant, 1978, Journal of virology.

Endogenous mink (Mustela vison) type C virus isolated from sarcoma virus-transformed mink cells

C. Sherr, G. Todaro, R. Benveniste, 1978, Journal of virology.

Evolution of type C viral genes: origin of feline leukemia virus

C. Sherr, G. Todaro, R. Benveniste, 1975, Science.

The fms gene and the CSF-1 receptor.

C. Sherr, C. W. Rettenmier, 1986, Cancer surveys.

Infectious primate type C viruses: Three isolates belonging to a new subgroup from the brains of normal gibbons.

C. Sherr, G. Todaro, M. Lieber, 1975, Virology.

A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2

M. Roussel, D. Beach, C. Sherr, 1999, Oncogene.

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

J. Downing, C. Mullighan, C. Sherr, 2008, Genes & development.

The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.

C. Sherr, R. Williams, R. Williams, 2008, Cold Spring Harbor symposia on quantitative biology.

M. Roussel, C. Sherr, R. Ashmun, 1987, Molecular and cellular biology.

A guanine nucleotide-dependent phosphatidylinositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes.

C. Rock, C. Sherr, S. Jackowski, 1986, The Journal of biological chemistry.

Primate type C virus p30 antigen in cells from humans with acute leukemia.

C. Sherr, G. Todaro, 1975, Science.

Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL.

S. Lowe, E. de Stanchina, C. Sherr, 2015, Blood.

A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6.

C. Sherr, 2016, The New England journal of medicine.

Endogenous primate and feline type C viruses.

C. Sherr, R. Callahan, G. Todaro, 1975, Cold Spring Harbor symposia on quantitative biology.

Signaling by ABL oncogenes through cyclin D1.

M. Roussel, O. Witte, C. Sherr, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Developmentally Restricted Protection From Notch1-Induced T Cell Acute Lymphoblastic Leukemia by the Arf Tumor Suppressor.

C. Sherr, R. Williams, Emmanuel J. Volanakis, 2009 .

A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes.

J. Downing, S. Shurtleff, M. Roussel, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Structural features of the colony‐stimulating factor 1 receptor that affect its association with phosphatidylinositol 3‐kinase.

J. Downing, S. Shurtleff, C. Rock, 1990, The EMBO journal.

Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice

F. Zindy, M. Churchman, C. Sherr, 2009, Proceedings of the National Academy of Sciences.

BCR–ABL and CDKN2A: a dropped connection

C. Sherr, R. Williams, 2008, Nature Reviews Cancer.

Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.

C. Sherr, D. Bertwistle, 2007, Blood.

Ubiquitination of, and sumoylation by, the Arf tumor suppressor.

C. Sherr, R. Williams, K. Tago, 2006, The Israel Medical Association journal : IMAJ.

Expression of Arf Tumor Suppressor in Spermatogonia Facilitates Meiotic Progression in Male Germ Cells

S. Keeney, M. Churchman, C. Sherr, 2011, PLoS genetics.

myb-like transcription factor , DMP 1 . Interaction of D-type cyclins with a novel

C. Sherr, H. Hirai, 1996 .

Peptide antisera to human colony-stimulating factor 1 receptor detect ligand-induced conformational changes and a binding site for phosphatidylinositol 3-kinase

J. Downing, S. Shurtleff, C. Sherr, 1991, Molecular and cellular biology.

gag-pol junction of feline leukemia virus. Nucleotide sequence of the gag gene and

F. Galibert, C. Sherr, I. Laprevotte, 2012 .

Surprising regulation of cell cycle entry

C. Sherr, 2019, Science.

Expression arrays illuminate a way forward for mantle cell lymphoma.

Wenjian Yang, C. Sherr, W. Evans, 2003, Cancer cell.

Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities.

R. Houghten, C. Sherr, S. Sen, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Polymorphic control of subunit synthesis for the enzyme lactate dehydrogenase in the newt, Triturus viridescens.

C. Sherr, 1968, The Journal of experimental zoology.

Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA

C. Sherr, G. Todaro, Arup Sen, 1977, Cell.

For the public record: Status of oncogene research

C. Sherr, 1984 .

SYNTHESIS AND INTRACELLULAR TRANSPORT OF IMMUNOGLOBULIN IN SECRETORY AND NONSECRETORY CELLS *

J. Uhr, C. Sherr, I. Schenkein, 1971, Annals of the New York Academy of Sciences.

Random mutagenesis of CSF‐1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.

M. Roussel, C. Sherr, S. A. Hawkins, 1992, The EMBO journal.

Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice

J. Opferman, C. Sherr, Chunliang Li, 2017, Proceedings of the National Academy of Sciences.

Inhibition of cyclin D 1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway

Charles J. Sherr, J. Alan Diehl, F. Zindy, 2007 .

Novel mammalian cyclins (CYL genes) expressed during G1.

M. Roussel, C. Sherr, H. Matsushime, 1991, Cold Spring Harbor symposia on quantitative biology.

Molecular Cloning , Expression , and Chromosomal Localization of the Gene Encoding a Human Myeloid Membrane Antigen ( gpl 50 )

Sherr, Martine, Richard, 2013 .

Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor.

M. Roussel, C. Sherr, C. W. Rettenmier, 1988, Cold Spring Harbor symposia on quantitative biology.

Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.

J. Downing, M. Roussel, C. Sherr, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity.

M. Roussel, C. Sherr, C. W. Rettenmier, 1988, Blood.

Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1.

M. Roussel, C. Sherr, J. Heard, 1987, Oncogene research.

Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor.

M. Roussel, C. Sherr, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Recombinant bacteriophages containing the integrated transforming provirus of Gardner--Arnstein feline sarcoma virus.

C. Sherr, C. Garon, L. Donner, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.

C. Sherr, M. Essex, G. Todaro, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes

F. Galibert, C. Sherr, I. Laprevotte, 1982, Cell.

Cellular Senescence Minireview Mitotic Clock or Culture Shock?

R. DePinho, C. Sherr, Ronald A DePinho, 2000, Cell.

Isolation of type‐c viruses from the asian feral mouse mus musculus molossinus

C. Sherr, G. Todaro, M. Lieber, 1975, International journal of cancer.

Targeting CDK4 and CDK6: From Discovery to Therapy.

G. Shapiro, D. Beach, C. Sherr, 2016, Cancer discovery.

Endogenous New World primate type C viruses isolated from owl monkey (Aotus trivirgatus) kidney cell line.

C. Sherr, B. Fleckenstein, G. Todaro, 1978, Proceedings of the National Academy of Sciences of the United States of America.

The Pezcoller lecture: cancer cell cycles revisited.

C. Sherr, 2000, Cancer research.

Radioimmunoassay of the major group specific protein of endogenous baboon type C viruses: relation to the RD-114-CCC group and detection of antigen in normal baboon tissues.

C. Sherr, G. Todaro, 1974, Virology.

Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses.

C. Sherr, R. Callahan, G. Todaro, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Colony-Stimulating Factor 1 (Macrophage Colony-Stimulating-Factor)

C. Sherr, E. Stanley, 1991 .

Subcellular localization of glycoproteins encoded by the viral oncogene v-fms

M. Gonda, S. Anderson, C. Sherr, 1984, Journal of virology.

Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging

F. Zindy, M. Roussel, D. Quelle, 1997, Oncogene.

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

Steven K. Hanks, Charles J. Sherr, Martine F. Roussel, 1992, Cell.

S‐tropic murine type‐C viruses: Frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens

C. Sherr, G. Todaro, M. Lieber, 1974, International journal of cancer.

Nucleolar Arf sequesters Mdm2 and activates p53

Charles J. Sherr, Martine F. Roussel, M. Roussel, 1999, Nature Cell Biology.

NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination

John T. Poirier, Charles M. Rudin, Amanda R. Kulick, 2018, Science.

Transplantable murine tumors release mouse‐tropic and xenotropic type‐c viruses

C. Sherr, G. Todaro, M. Lieber, 1975, International journal of cancer.

Infectious C-type virus isolated from a baboon placenta

D. Livingston, C. Sherr, G. Todaro, 1974, Nature.

Mixed splenocyte cultures and graft versus host reactions selectively induce an “S-tropic” murine type C virus

C. Sherr, G. Todaro, M. Lieber, 1974 .

Immunoglobulin synthesis and secretion. 3. Incorporation of glucosamine into immunoglobulin on polyribosomes.

J. Uhr, C. Sherr, 1969, Proceedings of the National Academy of Sciences of the United States of America.

Nucleotide sequence of the gag gene and gag-pol junction of feline leukemia virus

F. Galibert, C. Sherr, I. Laprevotte, 1984, Journal of virology.

Interspecies antigenic determinants of the reverse transcriptases and p30 proteins of mammalian type C viruses

C. Sherr, G. Todaro, R. Benveniste, 1975, Journal of virology.

Activation of endogenous type‐C viral p30 antigen in chemically‐induced rat hepatocellular carcinomas

F. Becker, C. Sherr, 1978, International journal of cancer.

Isolation of heavy and light chains of immunoglobulin from the surfaces of lymphoid cells.

J. Uhr, C. Sherr, E. Vitetta, 1971, Journal of immunology.

Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23

Charles J. Sherr, C. Sherr, Masataka Sugimoto, 2004, Molecular and Cellular Biology.

CELL SURFACE IMMUNOGLOBULIN

J. Uhr, C. Sherr, B. Zeligs, 1972, The Journal of experimental medicine.

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

S. Shurtleff, M. Roussel, D. Bar-Sagi, 1993, Genes & development.

Targeting CDK 4 and CDK 6 : From Discovery to Therapy

G. Shapiro, D. Beach, C. Sherr, 2015 .

p 27 Kip 1 , a cyclin-Cdk inhibitor , links transforming growth factor-13 and contact inhibition to cell cycle arrest

James M. Roberts, J. Massagué, K. Polyak, 2007 .

D-type cyclins.

C. Sherr, C J Sherr, 1995, Trends in biochemical sciences.

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation

J. Massagué, K. Polyak, C. Sherr, 1994, Cell.

Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.

Mei-Ling Kuo, Martine F Roussel, M. Roussel, 2003, Molecular cell.

Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.

A T Look, A. Look, M. Roussel, 1992, Genomics.

Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas.

F. Zindy, J. Rehg, D. H. Randle, 2001, Genes & development.

Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex

M. Roussel, R. Kriwacki, C. Sherr, 2000, Molecular and Cellular Biology.

E1A signaling to p53 involves the p19(ARF) tumor suppressor.

S. Lowe, F. Zindy, M. Roussel, 1998, Genes & development.

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

F. Zindy, C. Sherr, R. Ashmun, 1995, Cell.

Forging a signature of in vivo senescence

N. Sharpless, C. Sherr, 2015, Nature Reviews Cancer.

Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase

C. Sherr, J. Kato, M. Matsuoka, 1994, Molecular and cellular biology.

Cell Cycle–Targeted Cancer Therapies

J. Bartek, C. Sherr, 2017 .

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Amanda R. Kulick, S. Lowe, E. Stanchina, 2020, Cell.

Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.

C. Sherr, T. Lu, B. Sorrentino, 2011, Blood.

Hzf regulates adipogenesis through translational control of C/EBPα

H. Okano, M. Takagi, C. Sherr, 2008, The EMBO journal.

Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells

D. Finkelstein, C. Sherr, Chunliang Li, 2013, Proceedings of the National Academy of Sciences.

Divorcing ARF and p53: an unsettled case

C. Sherr, 2006, Nature Reviews Cancer.

Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.

S. Shurtleff, F. Behm, S. Raimondi, 1995, Blood.

Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.

C. Sherr, M. Boothby, Emmanuel J. Volanakis, 2013, Experimental hematology.

Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.

F. Zindy, M. Roussel, Chunxu Qu, 2010, Cancer research.

Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.

M. Roussel, J. Cleveland, T. Baudino, 2003, Molecular cell.

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

M. Roussel, J. Cleveland, C. M. Eischen, 1999, Genes & development.

Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling

S. Shurtleff, J. Cleveland, C. Sherr, 1991, Nature.

Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases.

M. Roussel, C. Sherr, M. Adachi, 1997, Blood.

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

M. Roussel, C. Sherr, R. Ashmun, 1995, Molecular and cellular biology.

A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase

C. Sherr, J. Diehl, C J Sherr, 1997, Molecular and cellular biology.

Frequent Deletion of p16*NK4a/MTSl and in Pediatric Acute Lymphoblastic Leukemia

J. Downing, S. Shurtleff, F. Behm, 2011 .

Frequent Deletion of p 16 * NK 4 a / MTSl and i Pediatric Acute Lymphoblastic Leukemia

Downing, S. Shurtleff, F. Behm, 2002 .

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Heather L. Mulder, M. Relling, J. Rehg, 2011, Blood.

Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

C. Sherr, R. Williams, W. den Besten, 2007, Genes & development.

The D-Type Cyclins: A Historical Perspective

C. Sherr, P. Sicinski, 2018 .

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

M. Roussel, C. Sherr, R. Williams, 2006, Proceedings of the National Academy of Sciences of the United States of America.

The RING domain of Mdm2 can inhibit cell proliferation.

M. Roussel, C. M. Eischen, C. Sherr, 2002, Cancer research.

The RING Domain of Mdm 2 Can Inhibit Cell Proliferation 1

M. Roussel, C. M. Eischen, C. Sherr, 2002 .

Nucleotide sequence and structural organization of the human FMS proto-oncogene.

F. Galibert, C. Sherr, A. Hampe, 1989, Oncogene research.

Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes

A. Look, M. Roussel, C. Sherr, 1988, Cell.

Colony-stimulating factor-1 receptor.

C. Sherr, 1990, Blood.

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo

F. Zindy, M. Roussel, J. Cleveland, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms

J. Downing, M. Roussel, C. Sherr, 1989, Molecular and cellular biology.

Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In Vivo

S. Elledge, R. DePinho, M. Roussel, 1999, Molecular and Cellular Biology.

Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.

C. Sherr, R. Williams, Emmanuel J. Volanakis, 2009, Blood.

Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein

C. Sherr, R. Williams, M. Kuo, 2005, Cell cycle.

Cell surface expression of v-fms-coded glycoproteins is required for transformation

A. Look, M. Roussel, C. Sherr, 1984, Molecular and cellular biology.

The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.

M. Hatten, F. Zindy, M. Roussel, 2005, Genes & development.

Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes

C. Sherr, R. Ashmun, C J Sherr, 1990, Molecular and cellular biology.

Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.

F. Zindy, M. Roussel, R. Gilbertson, 2007, Cancer research.

Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor

Asif J. Chaudhry, M. McMahon, C. Sherr, 2005, Molecular and Cellular Biology.

N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.

F. Zindy, M. Roussel, R. Eisenman, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf

E. Flores, C. Sherr, M. Cho, 2009, The EMBO journal.

p53-Dependent and -independent functions of the Arf tumor suppressor.

F. Zindy, M. Roussel, C. Sherr, 2005, Cold Spring Harbor symposia on quantitative biology.

Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.

F. Zindy, M. Roussel, Richard J Smeyne, 2003, Cancer research.

Hemangiosarcomas , Medulloblastomas , and Other Tumors in Ink 4 c / p 53-null Mice 1

F. Zindy, M. Roussel, Richard J Smeyne, 2003 .

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

M. Roussel, C. Sherr, M. Cheng, 1998, Genes & development.

Differential post-transcriptional regulation of two Ink4 proteins, p18Ink4c and p19Ink4d

M. Roussel, C. Sherr, O. Ayrault, 2008, Cell cycle.

INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy

F. Zindy, M. Roussel, C. Sherr, 2000, Molecular and Cellular Biology.

Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.

F. Zindy, M. Roussel, Richard J Smeyne, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.

F. Zindy, M. Roussel, J. Morgan, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.

A. Balmain, G. Peters, D. Quelle, 1995, Cancer research.

Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.

J. Downing, S. Shurtleff, V. Valentine, 1995, Genomics.

Cloning and characterization of murine p16INK4a and p15INK4b genes.

G. Hannon, M. Serrano, D. Beach, 1995, Oncogene.

Bared essentials of CDK2 and cyclin E

James M. Roberts, C. Sherr, 2003, Nature Genetics.

Hzf, a p53-Responsive Gene, Regulates Maintenance of the G2 Phase Checkpoint Induced by DNA Damage

C. Sherr, M. Sugimoto, Adam Gromley, 2006, Molecular and Cellular Biology.

Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.

M. Roussel, C. Sherr, K. Inoue, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a type C virus released from the porcine cell line PK(15).

C. Sherr, G. Todaro, M. Lieber, 1974, Virology.

Isolation of a type C virus (FS-1) from the European Wildcat (Felis sylvestris).

C. Sherr, G. Todaro, M. Lieber, 1975, Virology.

Type C viruses: Natural derivatives of cellular genes involved in malignant transformation

C. Sherr, G. Todaro, 1979, Springer Seminars in Immunopathology.

A new class of genetically transmitted retravirus isolated from Mus cervicolor.

C. Sherr, R. Callahan, G. Todaro, 1976, Proceedings of the National Academy of Sciences of the United States of America.

INTERSPECIES TRANSFER OF RNA TUMOR VIRUS GENES: IMPLICATIONS FOR THE SEARCH FOR “HUMAN” TYPE C VIRUSES

C. Sherr, G. Todaro, R. Benveniste, 1976 .

Type C viral expression in primate tissues.

C. Sherr, G. Todaro, R. Benveniste, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

M. Roussel, C. Sherr, V. Sexl, 1998, Proceedings of the National Academy of Sciences of the United States of America.

IMMUNOGLOBULIN SYNTHESIS AND SECRETION

J. Uhr, C. Sherr, Jonathan W. Uhr, 1971, The Journal of experimental medicine.

Simultaneous Gene Editing by Injection of mRNAs Encoding Transcription Activator-Like Effector Nucleases into Mouse Zygotes

R. Qi, M. Valentine, V. Valentine, 2014, Molecular and Cellular Biology.

Type C viruses of baboons: isolation from normal cell cultures.

C. Sherr, G. Todaro, M. Lieber, 1974, Cell.

A new class of murine retroviruses: immunological and biochemical comparison of novel isolates from Mus cervicolor and Mus caroli.

C. Sherr, R. Callahan, G. Todaro, 1977, Virology.

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma

Darjus F. Tschaharganeh, S. Armstrong, S. Lowe, 2014, Genes & development.

Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.

A. Shilatifard, M. Roussel, P. Northcott, 2017, Cell reports.

Mammalian G1 cyclins and cell cycle progression.

C. Sherr, 1995, Proceedings of the Association of American Physicians.

[35] Purification and assay of murine leukemia viruses

C. Sherr, G. Todaro, 1979 .

Regulation of mononuclear phagocyte proliferation by colony-stimulating factor-1.

C. Sherr, 1990, International journal of cell cloning.

onc sequences (v-fes) of Snyder–Theilen feline sarcoma virus are derived from noncontiguous regions of a cat cellular gene (c-fes)

C. Sherr, F. Wong-Staal, G. Franchini, 1981, Nature.

The c-fms Proto-Oncogene and the CSF-1 Receptor

C. Sherr, E. Stanley, 1986 .

hepatocellular carcinoma CDK 9-mediated transcription elongation is required for MYC addiction Material Supplemental

Darjus F. Tschaharganeh, S. Armstrong, S. Lowe, 2014 .

Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase

D. Morgan, C. Sherr, J. Kato, 1994, Molecular and cellular biology.

Mitogenic response to colony-stimulating factor 1.

C. Sherr, 1991, Trends in genetics : TIG.

Regulation of the CD13/Aminopeptidase N Gene by DMP1, a Transcription Factor Antagonized by D-Type Cyclins*

C. Sherr, Kazushi Inoue, L. Shapiro, 1998, The Journal of Biological Chemistry.

Ink 4-Arf Locus in Cancer and Aging

C. Sherr, 2013 .

Ink4‐Arf locus in cancer and aging

C. Sherr, 2012, Wiley interdisciplinary reviews. Developmental biology.

Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1

H. Hirai, C. Sherr, H. Hirai, 1996, Molecular and cellular biology.

Mouse medulloblastoma driven by CRISPR activation of cellular Myc

M. Roussel, Beisi Xu, D. Finkelstein, 2018, Scientific Reports.

Arf induces p53-dependent and -independent antiproliferative genes.

Deanna Naeve, Eric J Duncavage, Deqing Pei, 2003, Cancer research.

Nucleophosmin/b23 Arf Tumor Suppressor Protein with Physical and Functional Interactions of The

C. Sherr, D. Bertwistle, M. Sugimoto, 2022 .

Growth factor-regulated G1 cyclins.

C. Sherr, 1994, Stem cells.

Precursors of collagen secreted by cultured human fibroblasts.

C. Sherr, E. Epstein, B. Goldberg, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Arf Induces p 53-dependent and-independent Antiproliferative Genes 1 , 2

M. Roussel, D. Pei, Cheng Cheng, 2003 .

Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression

Michael C. Ostrowski, M. Roussel, C. Sherr, 1992, Molecular and cellular biology.

Factor 1 Receptor Detect Ligand-Induced Conformational Changesanda Binding Site forPhosphatidylinositol

J. Downing, S. Shurtleff, C. Sherr, 1991 .

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Amanda R. Kulick, S. Lowe, E. Stanchina, 2021, Cell.

N-Terminal Polyubiquitination of the ARF Tumor Suppressor, A Natural Lysine-Less Protein

C. Sherr, M. Kuo, W. D. Besten, 2004, Cell cycle.

Isolation of a disulfide-stabilized, three-chain polypeptide fragment unique to the precursor of human collagen.

C. Sherr, M. Taubman, B. Goldberg, 1973, The Journal of biological chemistry.

Antibodies to a Precursor of Human Collagen

C. Sherr, B. Goldberg, 1973, Science.

Endogenous feline (RD-114) and baboon type C viruses have related specific RNA-binding proteins and genome binding sites.

C. Sherr, G. Todaro, A. Sen, 1978, Virology.

Endogenous baboon type C virus (M7): biochemical and immunologic characterization.

C. Sherr, G. Todaro, M. Lieber, 1974, Virology.

Type C viral antigens in man. I. Antigens related to endogenous primate virus in human tumors.

C. Sherr, G. Todaro, 1974, Proceedings of the National Academy of Sciences of the United States of America.

senescence of murine bone marrow-derived preB cells and macrophages

F. Zindy, M. Roussel, D. H. Randle, 2001 .

Autophagy by ARF: a short story.

C. Sherr, 2006, Molecular cell.

Abstracts of papers presented at the 1994 Meeting on the Cell Cycle, May 18-May 22, 1994

David H. Beach, Charles J. Sherr, D. Beach, 1994 .

Immunoglobulin synthesis and secretion. V. Incorporation of leucine and glucosamine into immunoglobulin on free and bound polyribosomes.

J. Uhr, C. Sherr, 1970, Proceedings of the National Academy of Sciences of the United States of America.

Purification and assay of murine leukemia viruses.

C. Sherr, G. Todaro, 1979, Methods in Enzymology.

Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.

J. Downing, M. Roussel, C. Sherr, 1990, Oncogene.

Immunoglobulin synthesis on free and bound polyribosomes of rabbit lymph node cells.

J. Uhr, C. Sherr, 1971, Journal of immunology.

Acquired palbociclib resistance in KRAS-mutant lung cancer

C. Sherr, 2018, Oncotarget.

Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation

J. Downing, M. Roussel, C. Sherr, 1990, Molecular and cellular biology.

The colony-stimulating factor 1 receptor: pleiotropy of signal-response coupling.

C. Sherr, 1990, Lymphokine research.

In Vivo Interactions p57 KIP2 Inhibitor: Cooperative Cyclin D- and E-Dependent Kinases and the

S. Elledge, R. Burde, R. DePinho, 2013 .

Secretion and extracellular processing of procollagen by cultured human fibroblasts.

C. Sherr, B. Goldberg, 1973, Proceedings of the National Academy of Sciences of the United States of America.

Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.

J. Rowley, R. Larson, M. L. Le Beau, 1986, Science.

Developmental strategies for evasion of Arf tumor suppression

C. Sherr, Emmanuel J. Volanakis, 2010, Cell Cycle.

Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.

Jun Kato, C. Sherr, J. Kato, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1).

J. Downing, S. Raimondi, C. Naeve, 1999, Gene.

Ultra-High Resolution Analysis of Genomic Alterations in High-Risk Acute Lymphoblastic Leukemia.

J. Downing, S. Shurtleff, Jing Ma, 2008 .

CDK inhibitors: positive and negative regulators of G1-phase progression.

James M. Roberts, C. Sherr, 1999, Genes & development.

Targeting CDK4 and CDK6: From Discovery to Therapy.

G. Shapiro, D. Beach, C. Sherr, 2016, Cancer discovery.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

F. Zindy, M. Roussel, G. Zambetti, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Leukemia and lymphoma 1987

C. Sherr, 1987, Cell.

Erratum: Forging a signature of in vivo senescence

N. Sharpless, C. Sherr, 2015, Nature Reviews Cancer.

CELL SURFACE IMMUNOGLOBULIN

J. Uhr, C. Sherr, B. Zeligs, 1972, The Journal of experimental medicine.

human chromosome 5. locus and its assignment to Molecular cloning of the c-fms

M. Roussel, C. Sherr, P. Barker, 2013 .

Molecular Cloning ofthec-fmsLocusandItsAssignment to HumanChromosome 5

M. Roussel, F. Ruddle, C. Sherr, 1983 .

Simultaneous Gene Editing by Injection of mRNAs Encoding Transcription Activator-Like Effector Nucleases into Mouse Zygotes

R. Qi, M. Valentine, V. Valentine, 2014, Molecular and Cellular Biology.